loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 206829 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 CUBIST PHARMS LLC (1)

filter

01 POWDER;INTRAVENOUS (1)

filter

01 RX (1)

filter

01 ZERBAXA (1)

filter

01 Yes (1)

URL Supplier Web Content
POWDER; INTRAVENOU...
EQ 1GM BASE/VIAL;E...
2014-12-19
206829
ZERBAXA
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 206829

Looking for FDA Orange Book APPLICATION 206829 1

19

CUBIST PHARMS INC, based in Switzerland, is a pharmaceutical company.

One of their notable products is CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM, with a corresponding application number 206829.

Regulatory Information RX

With a dosage strength EQ 1GM BASE/VIAL;EQ 0.5GM BASE/VIAL

Dosage Form Route POWDER; INTRAVENOUS

Reference Listed Drug Yes

Approved since 2014-12-19

Post Enquiry
POST ENQUIRY